Print this page
Saturday, 11 October 2014 08:43

Anticoagulation news items. Week commencing 6th October 2014

Anticoagulation in adults with congenital heart disease: The who, the when and the how?


This article reviews the current use of anticoagulation in patients with congenital heart disease. It discusses treatment and monitoring with warfarin, heparin and the new oral anticoagulants, and who and when to treat.


Medicines Evidence Commentary : Acute coronary syndromes: duration of dual antiplatelet therapy after drug-eluting stent implantation

National Institute for Health and Care Excellence

A randomised controlled trial reported that continuing dual antiplatelet therapy beyond a year after stent implantation did not statistically significantly reduce the risk of the combined outcome of death or cardiovascular events compared with continuing aspirin monotherapy....



The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at: